Last reviewed · How we verify
NCT03579667
Lipid Profile and Weight After Pregnancy
NA trial testing Diet intervention in Cardiovascular Risk Factor in 30 participants. Completed in 29 September 2021.
29 September 2021
Quick facts
| Lead sponsor | University of Oslo |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 15 August 2017 |
| Primary completion | 29 September 2021 |
| Estimated completion | 29 September 2021 |
| Sites | 1 location across Norway |
Drugs / interventions tested
- Diet intervention
Conditions studied
- Cardiovascular Risk Factor — all drugs for Cardiovascular Risk Factor →
- Body Weight — all drugs for Body Weight →
Sponsor
University of Oslo
Who can join
18 and older, female only, with Cardiovascular Risk Factor or Body Weight. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A randomized controlled trial aiming to investigate the effects of diet behavior intervention postpartum on body weight and lipid and metabolite profile in overweight and obese women in Oslo, Norway
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Dietary treatment postpartum in women with obesity reduces weight and prevents weight gain: a randomised controlled trial.
Øhman EA, Fossli M, Ottestad I, Holven KB, et al · · 2023 · cited 6× · PMID 37752466 · DOI 10.1186/s12884-023-05976-w
Verify or expand the search:
- PubMed search for NCT03579667
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Diet intervention
Trials testing the same drug.
- NCT05960396 — Exploring the Mechanism of Dietary Pattern Improving MAFLD · NA · unknown
- NCT05942287 — The Effect of Obesity and Weight Loss in Heart Failure With Reduced Ejection Fraction. · NA · recruiting
- NCT05887674 — Shanghai Non-pharmacological Intervention for Mild Cognitive Impairment and Mild Alzheimer's Disease · NA · recruiting
- NCT05025943 — Omega-3 Fatty Acid Dietary Intervention (O3DI) · NA · completed
- NCT04930276 — Diet-glucose-gut Microbiome Net in Women With GDM · NA · unknown
Other recruiting trials for Cardiovascular Risk Factor
Currently open trials in the same condition.
- NCT07268781 — Impact of Golden Rice-Piper Crocatum Cookies on Lipid Control in Diabetes Mellitus Patients · NA · active not recruiting
- NCT06225544 — Lumasiran in Hyperoxalaemic Patients on Haemodialysis · Phase 2 · recruiting
- NCT06372054 — TORNADO-Omics Techniques and Neural Networks for the Development of Predictive Risk Models · recruiting
- NCT05887622 — The Potassium Supplementation Study · NA · recruiting
- NCT04962061 — A Combined Multidomain Intervention to Prevent Cognitive Decline Associated With Cardiovascular Risk Factors. · NA · recruiting
Other University of Oslo trials
Trials by the same sponsor.
- NCT07346911 — Digital Interventions for Relapse Prevention in Adolescence · NA · not yet recruiting
- NCT07499219 — Preliminary Testing and Development of a Short Digital Intervention for Patients on Waiting Lists for Psychological Trea · NA · not yet recruiting
- NCT07408687 — Mechanisms Of Change in Psychotherapy: The Effects of Cognitive Behavioral Therapy and Psychodynamic Therapy in Once - V · NA · not yet recruiting
- NCT07287072 — Pain Reprocessing Therapy for Chronic Primary Pain · NA · not yet recruiting
- NCT07428694 — From Bench to Bedside: A Machine Learning Tool for the Detection of Inspiratory Leak · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03579667 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Oslo
- Last refreshed: 27 October 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03579667.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing